US Patent Issued to Suzhou Smartnuclide Biopharmaceutical on Aug. 5 for "PD-L 1-binding polypeptide and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,378,317, issued on Aug. 5, was assigned to Suzhou Smartnuclide Biopharmaceutical Co. Ltd. (Jiangsu, China).

"PD-L 1-binding polypeptide and use thereof" was invented by Tao Xu (Suzhou, China), Yan Sun (Suzhou, China), Hao Qi (Suzhou, China), Haijing Du (Suzhou, China), Tingting Hu (Suzhou, China), Yanling Yang (Suzhou, China), Fangfang Li (Suzhou, China), Qi Zhao (Suzhou, China) and Songbing Qin (Suzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to the field of biomedicine. Specifically, the invention relates to PD-L1 binding polypeptides and uses thereof in particular, uses m detecting and/or diagnosing PD-L1 related dis...